References
- Speroff L., De Chemey A. Evaluation of a new generation of oral contraceptives. The Advisory Board for new progestins. Obstet. Gynecol. 1993; 81: 1034–47
- Huisveld I. A., Hospers J. E. H., Meijers J. C.M., Starkenburg A. E., Erich W. B. M., Bouma B. M. Oral contraceptives reduce total protein S, but not free protein S. Thromb. Res. 1987; 45: 109–14
- David J. L., Gaspard U. J., Gillain D., Raskinet R., Lepot M. R. Hemostasis profile in women taking low-dose oral contraceptives. Am. J. Obstet. Gynecol. 1990; 163: 420–3, (Suppl.)
- Vandenbroucke J. P., Koster T., Briët E., Reitsma P. H., Bertina R., Rosendaal F. R. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453–7